Metrics
Notes
- The fund sold its stake in Crispr. The link to the post explaining why we sold can be found here.
- A new stake in Ibio Pharma was started on Monday. The link explaining its purchase can be found here. Surprisingly, it is getting to a valuation where a sale might occur.
- Some of the proceeds of the Crispr sale went to purchase more shares of Fuel Cell.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
No comments:
Post a Comment